Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash | $03 | $04 | $04 | $1314 | |||
| Current assets | $03 | $04 | $1314 | ||||
| Total assets | $05 | $05 | $05 | $05 | $03 | $04 | $5.1K4 |
| Current liabilities | $262.3K5 | $262.3K5 | $275.4K5 | $294.0K5 | $22.6K3 | $36.4K4 | $99.3K4 |
| Long-term debt | $23.0K4 | $04 | |||||
| Total liabilities | $22.6K3 | $59.4K4 | $99.3K4 | ||||
| Retained earnings | -$179.4M4 | ||||||
| Shareholders’ equity | -$262.3K5 | -$262.3K5 | -$275.4K5 | -$294.0K5 | -$22.6K4 | -$59.4K4 | -$94.2K4 |
| Shares outstanding | 146.9M shares5 | 256.1M shares8 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
What it owns
What NUNZIA PHARMACEUTICAL Co reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
Leadership
Who has led NUNZIA PHARMACEUTICAL Co, and when. Pick a name to see everywhere that person has worked.
Chief financial officer
- Chief financial officerKingman L. Hitz Apr 17, 2006 to Apr 17, 20069
Former names
Timeline
Filings
14 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 2 major events, 3 other. The latest 14:
- Jul 20, 202315-12G FORM 15 EDGAR
- Nov 14, 202210-Q EDGAR
- Oct 3, 202210-Q EDGAR
- May 23, 202210-Q QUARTERLY REPORT EDGAR
- May 16, 2022NT 10-Q EXTENSION EDGAR
- Apr 15, 202210-K EDGAR
- Mar 31, 2022NT 10-K EDGAR
- Mar 29, 202210-Q/A AMENDMENT #1 TO FORM 10-Q EDGAR
- Mar 29, 202210-Q/A AMENDMENT #1 TO FORM 10-Q EDGAR
- Mar 29, 202210-Q/A AMENDMENT #1 TO FORM 10-Q EDGAR
- Mar 29, 202210-K/A EDGAR
- Mar 18, 20228-K NUNZIA PHARMACEUTICAL COMPANY - FORM 8-K SEC FILING EDGAR
- Mar 2, 20228-K NUNZIA PHARMACEUTICAL COMPANY - FORM 8-K SEC FILING EDGAR
- Nov 10, 202110-Q NUNZIA PHARMACEUTICAL COMPANY - FORM 10-Q SEC FILING EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How NUNZIA PHARMACEUTICAL Co is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARNUNZIA PHARMACEUTICAL Co1
- CIK0000886093
- Employer ID (EIN)87-04420901
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inUtah1
- Fiscal year endsDecember 311
- Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
- Business address1627 West 14Th Street, Long Beach, CA 908131
- Phone714-609-91171
- Shares outstanding434,514,578 as of Nov 14, 20227
- Public float$23.0M as of Jun 30, 20214
- On EDGAR sinceMar 31, 19971
- Filings208 in all: 4 (46), 8-K (29), 10-Q (27), 10QSB (24), 3 (9), 4/A (9), 10-K (8), 10KSB (8)1
All 28 form types
10-Q/A (7), 8-K/A (6), NT 10-K (4), NT 10-Q (4), S-8 (4), 10QSB/A (3), SC 13G/A (3), 10-K/A (2), 15-12G (2), SC 13D/A (2), SC 13G (2), 10-12B (1), 10-12G (1), 10-12G/A (1), 10KSB40 (1), 3/A (1), DEF 14A (1), RW (1), S-8 POS (1), SC 13D (1)
- Latest filingsAnnual report (10-K) Apr 15, 2022
Quarterly report (10-Q) Nov 14, 2022
Proxy statement (DEF 14A) Dec 3, 1997
Latest 8-K (8-K) Mar 18, 2022
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGAREntered a material agreement
- 11SEC EDGAREntered a material agreement